Australian and New Zealand perfusion survey: Management and procedure

Journal of Extra-Corporeal Technology

Volumn 41, Issue 2, 2009, Pages 64-72

  Tuble, Sigrid C ^a   Willcox, Timothy W ^b   Baker, Robert A ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Survey questionnaire cardiopulmonary bypass

Indexed keywords

AMINOCAPROIC ACID; APROTININ; BARBITURIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DROPERIDOL; ENFLURANE; GLYCERYL TRINITRATE; HALOTHANE; ISOFLURANE; MANNITOL; METARAMINOL; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENTOLAMINE; PHENYLEPHRINE; STEROID; TRANEXAMIC ACID;

ANTICOAGULATION; AUSTRALIA; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL PRACTICE; CONFERENCE PAPER; HEART ARREST; HEART MUSCLE; HEART PROTECTION; HIGH RISK PATIENT; HYPOTHERMIA; MEDICAL AUDIT; MORBIDITY; MORTALITY; NEW ZEALAND; OPEN ENDED QUESTIONNAIRE; PERFUSION; PREOPERATIVE CARE; QUALITY CONTROL; TEMPERATURE; ARTICLE; DEEP HYPOTHERMIC CIRCULATORY ARREST; HUMAN; INFORMATION PROCESSING; INSTRUMENTATION; METHODOLOGY; QUESTIONNAIRE; STANDARD;

AUSTRALIA; CARDIOPULMONARY BYPASS; CIRCULATORY ARREST, DEEP HYPOTHERMIA INDUCED; DATA COLLECTION; HEART ARREST, INDUCED; HUMANS; NEW ZEALAND; PERFUSION; QUESTIONNAIRES;

EID: 70349570406     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Baker RA, Willcox TW. Australian and New Zealand perfusion survey: Equipment and monitoring. J Extra Corpor Technol. 2006; 38:220-9.
2. Wajon PR, Walsh RG, Symons NLP. A survey of cardiopulmonary bypass perfusion practices in Australia in 1992. Anaesth Intensive Care. 1993;21:814-21.
3. Jenkins OF, Morris M, Simpson JM. Australasian perfusion incident survey. Perfusion. 1997;12:279-88.
4. Silvay G, Ammar T, Reich DL, Vela-Cantos F, Joffe D, Ergin AM. Cardiopulmonary bypass for adult patients: A survey of equipment and techniques. J Cardiothorac Vasc Anesth. 1995;9:420-4.
5. Mejak BL, Stammers A, Rauch E, Vang A, Viessman T. A retrospective study on perfusion incidents and safety devices. Perfusion. 2000;15:51-61.
6. Stammers AH, Mejak BL. An update on perfusion safety: Does the type of perfusion practice affect the rate of incidents related to cardiopulmonary bypass? Perfusion. 2001;16:189-98.
7. Belway D, Rubens FD, Wozny D, Henley B, Natahn HJ. Are we doing everything we can to conserve blood during bypass? A national survey. Perfusion. 2005;20:237-41.
8. Charriere JM, Pelissie J, Verd C, et al. Survey: Retrospective survey of monitoring/safety devices and incidents of cardiopulmonary bypass for cardiac surgery in France. J Extra Corpor Technol. 2007;39:142-57.
9. DioDato CP, Likosky DS, DeFoe GR, et al. Cardiopulmonary bypass recommendations in adults: The Northern New England experience. J Extra Corpor Technol. 2008;40:16-20.
10. Nussmeier NA. Management of temperature during and after cardiac surgery. Tex Heart Inst J. 2005;32:472-6.
11. Hogue CW, Palin CA, Arrowsmith JE. Cardiopulmonary bypass management and neurologic outcomes: An evidence-based appraisal of current practices. Anesth Analg. 2006;103:21-37.
12. Hartman G. Pro: During cardiopulmonary bypass for elective coronary artery bypass grafting, perfusion pressure should routinely be greater than 70 mmHg. J Cardiothorac Vasc Anesth. 1998;12:358-60.
13. Gold JP, Charlson ME, Williams-Russo P, et al. Improvement of outcomes after coronary artery bypass: A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg. 1995;110:1302-11.
14. Charlson ME, Peterson JC, Krieger KH, et al. Improvement of outcomes after coronary artery bypass II: A randomized trial comparing intraoperative high versus customized mean arterial pressure. J Card Surg. 2007;22:465-72.
15. Cartwright CR, Mangano CM. Con: During cardiopulmonary bypass for elective coronary artery bypass grafting, perfusion pressure should not routinely be greater than 70 mmHg. J Cardiothorac Vasc Anesth. 1998;12:361-4.
16. Anttila V, Hagino I, Zurakowski D, et al. Specific bypass condi tions determine safe minimum flow rate. Ann Thorac Surg. 2005;80: 1460-7.
17. Murkin JM, Martzke JS, Buchan AM, Bentley C, Wong CJ. A randomized study of the influence of perfusion technique and pH management strategy in 316 patients undergoing coronary artery bypass surgery. I. Mortality and cardiovascular morbidity. J Thorac Cardiovasc Surg. 1995;110:340-8.
18. Ji B, Undar A. An evaluation of the benefits of pulsatile versus nonpulsatile perfusion during cardiopulmonary bypass procedures in pediatric and adult cardiac patients. ASAIO J. 2006;52:357-61.
19. Undar A, Rosenberg G, Myers JL. Major factors in the controversy of pulsatile versus nonpulsatile flow during acute and chronic cardiac support. ASAIO J. 2005;51:173-5.
20. Guru V, Omura J, Alghamdu AA, Weisel R, Fremes SE. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation. 2006;114:I331-8.
21. Okamoto F, Allen BS, Buckberg GD, Young H, Bugyi H, Leaf J. Studies of controlled reperfusion after ischemia. XI: Reperfusate composition: Interaction of marked hyperglycemia and marked hyperosmolarity in allowing immediate contractile recovery after four hours of regional ischemia. J Thorac Cardiovasc Surg. 1986;92:583-93.
22. Shann KG, Likosky DS, Murkin JM, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg. 2006;132:283-90.
23. Edwards FH, Ferraris VA, Shahian DM, et al. Gender-specific practice guidelines for coronary artery bypass surgery: Perioperative management. Ann Thorac Surg. 2005;79:2189-94.
24. Ferraris VA, Ferraris SP, Saha SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007;83:S27-86.
25. Rubens FD, Boodhwani M, Mesana T, Wozny D, Wells G, Nathan HJ. The cardiotomy trial: A randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation. 2007;116:I89-97.
26. Mangano DT, Miao Y, Vuylsteke A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007;297:471-9.
27. Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319-31.
28. American Society of ExtraCorporeal Technology. AmSECT Guidelines for Perfusion Practice. Available at: www.amsect.org. Accessed May 21, 2008.
29. American Academy of Cardiovascular Perfusion. Guidelines of Per fusion Practice: A Statement of The American Academy of Cardiovascular Perfusion. Available at: www.theaacp.com. Accessed May 21, 2008.
30. Svenmarker S, Haggmark S, Jansson E, Lindholm R, Appelblad M, Aberg T. Quality assurance in clinical perfusion. Eur J Cardiothorac Surg. 1998;14:409-14.
31. Palanzo DA. Perfusion safety: Defining the problem. Perfusion. 2005;20:195-203.
32. Baker RA, Newland RF. Continuous quality improvement of perfusion practice: The role of electronic data collection and statistical control charts. Perfusion. 2008;23:7-16.
33. Newland R, Baker RA, Stanley R, Place K, Willcox TW. The Perfusion Downunder Collaborative Database project. J Extra Corpor Technol. 2008;40:159-65.